Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study
Dailin Rong, Bingjun He, Wenjie Tang, Sidong Xie, Sichi Kuang, Luigi Grazioli, Shahid M. Hussain, Yang Yang, Jin Wang
Abstract
The findings support gadobenate as a preferred agent over gadoxetate when performing liver MRI in patients at high risk for HCC.
Topics & Concepts
MedicineHepatocellular carcinomaRadiologyProspective cohort studyNuclear medicineMagnetic resonance imagingDynamic contrast-enhanced MRIDynamic contrastDiagnostic accuracyGold standard (test)CarcinomaUltrasoundPredictive value of testsHepatocellular Carcinoma Treatment and PrognosisMRI in cancer diagnosisLiver Disease Diagnosis and Treatment